"Mr. Croarkin served as the Chief Financial Officer of Nestlé Health Science S.A., a division of Nestlé focused on medicalized nutrition solutions for chronic medical conditions. Prior to this, Mr. Croarkin was Senior Vice President of Finance, Chief Financial Officer & Corporate Strategy Officer at Alcon, Inc., which was the world’s leading ophthalmic pharmaceutical and medical device company before its acquisition by Novartis in 2011. Before Alcon, Mr. Croarkin served as EVP and CFO of Nestlé Waters North America after working for Pepsico Incorporated for 11 years where he served in several global senior financial positions including Chief Financial Officer of Pepsi-Cola Latin America and Pepsi-Cola Canada. Mr. Croarkin began his career with AMAX, Inc. where he worked in treasury, corporate development and planning. He holds a BA in Economics from Georgetown University, an MBA in Finance from the University of Connecticut and a Diploma in French language from Alliance Francaise in Paris, France. Mr. Croarkin is currently a Director on the Board of Aerie Pharmaceuticals, Inc. and also serves as a panelist on the NASDAQ Listing Qualifications Panel. "

biomedical science